Vanda

Why Did Vanda Pharmaceuticals Hit A 52-Week High?

Why Did Vanda Pharmaceuticals Hit A 52-Week High?

Seeking Alpha

Vanda reports successful completion of pre-NDA meeting with FDA on tasimelteon

Vanda reports successful completion of pre-NDA meeting with FDA on tasimelteon

Yahoo/Fly on the Wall

Vanda pulls EU filing for schizophrenia drug

Vanda pulls EU filing for schizophrenia drug

Pharma Times, UK

This Week in Biotech

This Week in Biotech

Motley Fool

Vanda to stop developing anti-depressant, shares slip

Vanda to stop developing anti-depressant, shares slip

Reuters

This Week in Biotech: Part 1

This Week in Biotech: Part 1

Motley Fool

Vanda sleep drug effective in second late-stage trial

Vanda sleep drug effective in second late-stage trial

Reuters

Novartis drops long-acting version of Vanda Pharmaceuticals drug

Novartis drops long-acting version of Vanda Pharmaceuticals drug

Bizjournals.com

Cashed Up Biotech Vanda Could Keep On Falling

Cashed Up Biotech Vanda Could Keep On Falling

Seeking Alpha

4 Cash Loaded Biotech Stocks With Little Debt

4 Cash Loaded Biotech Stocks With Little Debt

Seeking Alpha